BIT.AX - Biotron Limited

ASX - ASX Delayed price. Currency in AUD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2019
30/06/2018
30/06/2017
30/06/2016
Total revenue
-
-
1
0
0
Cost of revenue
-
-
-
-
-
Gross profit
-
-
1
-
-
Operating expenses
Research development
1,195
1,116
1,693
3,155
3,132
Selling general and administrative
1,219
1,167
1,171
1,145
1,139
Total operating expenses
2,794
2,774
3,233
4,783
4,629
Operating income or loss
-2,794
-2,774
-3,233
-4,783
-4,629
Interest expense
-
-
-
-
-
Total other income/expenses net
1,074
1,073
1,623
1,659
1,548
Income before tax
-1,695
-1,612
-1,594
-3,093
-3,004
Income tax expense
0
0
0
0
0
Income from continuing operations
-1,695
-1,612
-1,594
-3,093
-3,004
Net income
-1,695
-1,612
-1,594
-3,093
-3,004
Net income available to common shareholders
-1,695
-1,612
-1,594
-3,093
-3,004
Reported EPS
Basic
-
-
-0.00
-0.01
-0.01
Diluted
-
-
-0.00
-0.01
-0.01
Weighted average shares outstanding
Basic
-
-
397,150
365,700
361,850
Diluted
-
-
397,150
365,700
361,850
EBITDA
-
-2,761
-3,221
-4,769
-4,613